Company: NCEL
Filing Date: 2025-09-10
Form Type: 424B3
Source: 0001213900-25-086600
Chunk: 833

Company: NewcelX Ltd.
Filing Date: 2025-09-10
Form: 424B3
Chunk 833
---
ieri Warrants”). The conversion was carried out in accordance with the terms of the convertible loan agreement dated November 22, 2023. As a result of the accrued interest amounting at USD $60,479 (approximately NIS 222,867), on May 4, 2025, the Company announced that it will issue to Mr. Ruggieri 36,233 ordinary shares, no par value; and 9,960 non -listedRuggieri Warrants, exercisable into ordinary shares. The Ruggieri Warrants shall have an exercise price equal to 110% of the conversion price (NIS 6.77) and shall be exercisable for a period of 42 months from the date of issuance. D. Loan agreement in the amount of NIS 1 million (USD $269 thousand), on beneficial terms, between the Company and Prof. Michel Revel On April 23, 2025, the Company announced that on April 22, 2025, the Company’s audit committee and Board of Directors approved the Company’s entry into a loan agreement, on beneficial terms, with Prof. Michel Revel, the Company’s Chief Scientific Officer, who is also a significant shareholder and a director of the Company (the “Loan Agreement”, accordingly), in accordance with the terms as follows: 1.Upon approval by the Company’s Board of Directors, Prof. Revel shall provide the Company with a loan in the amount of NIS 1 million (USD $269 thousand). The loan bears no interest and is not linked to any index and unsecured. 2.The loan shall remain in effect for a period of one year, which shall automatically renew for consecutive 12 -monthperiods, unless the parties agree to an earlier repayment in writing, at least 30 days prior to the end of the applicable term. 3.Subject to the approval of the Company’s general meeting of shareholders, the loan shall be converted into Company shares, at the earlier of: (i) a date close to the closing date of the Company’s merger with NLS, if and when completed, at the market price as that time (calculated as the average share price of the 14 trading days prior to the conversion date); or (ii) alternatively, if the Company conducts an equity financing round in proximity to the completion of the merger, any other equity financing. Annex G-45 Annex H VOTE ON INTERNET Go to http://www.vstocktransfer.com/proxy Click on Proxy Voter Login and log